Rockwell Medical (RMTI) Liabilities and Shareholders Equity (2010 - 2026)

Rockwell Medical (RMTI) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $56.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 7.41% year-over-year to $56.5 million; the trailing twelve-month figure through Jun 2026 stood at $228.6 million (up 2.56% YoY), and the FY2025 full-year result was $57.1 million, down 3.48% from the prior year.
• Liabilities and Shareholders Equity declined to $56.5 million in Q2 2026 per RMTI's latest filing, from $57.4 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $59.2 million in Q4 2024 and bottomed at $37.4 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $52.0 million across 5 years, with a median of $53.5 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity slumped 46.1% in 2022, then surged 39.41% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $46.6 million in 2022, then climbed by 11.88% to $52.2 million in 2023, then gained by 13.48% to $59.2 million in 2024, then dropped by 3.48% to $57.1 million in 2025, then fell by 1.08% to $56.5 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $56.5 million, $57.4 million, and $57.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.